Evestra Prodrug 6 Month Injectable

Description: Evestra is advancing research on a technology that could lead to long-acting injectable fertility control for women by applying its proprietary prodrug platform technology to the development of the product.

Product Details

User: Female

Hormonal: Yes

Delivery Method: Injectable

Duration Type: Short-acting

Duration: 6 months

Regimen:
  • one injection every 6 months

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: Evestra, Inc.

Project Phase: Discovery and Early Development

Development Stage: Prototype Development

Active Development: Yes

Status Details:
  • Received a grant in 2016 from the Bill & Melinda Gates Foundation.

Additional Information

References:

Vertical Tabs

Print